New share issue
The Board in Immunicum decided on February 12, 2013 to increase the Company’s share capital by issuing new shares to the public, without preferential rights for the Company’s existing shareholders.
The decision was made pursuant to the authorization to issue shares resolved by the Company’s AGM on 19 December 2012. The decision to issue new shares means that Immunicum’s share capital is increased by a maximum of 133 750 SEK by issuing a maximum of 2 675 000 new shares.
Subscription of shares shall be made during the period from 4 March to and including 22 March 2013. The subscription price in the rights issue has been fixed at 8 SEK per share, which means that the issue provides the Company up to 21,4 million SEK before issue costs.
Read more here: Press release – Immunicum’s listing on NASDAQ OMX First North